Sponsor pipeline

Charlotte Lemech clinical trial pipeline

Get alerts when Charlotte Lemech's trials change

1 active trials 1 recruiting 1 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-16
Primary completion pushed: 2024-09 → 2027-09
Recruitment opened
Completion pushed: 2026-09 → 2027-09
NCT06132438 Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma · Phase 1

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT06132438 Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma Glioblastoma Recruiting 2026-09-15

Disease areas by active trials

Glioblastoma (1)

Get alerts when Charlotte Lemech's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free